The University of Southampton
University of Southampton Institutional Repository

IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution

IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution
IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution

Follicular lymphoma B cells undergo continuous somatic hypermutation (SHM) of their immunoglobulin variable region genes, generating a heterogeneous tumor population. SHM introduces DNA sequences encoding N-glycosylation sites asparagine-X-serine/threonine (N-gly sites) within the V-region that are rarely found in normal B-cell counterparts. Unique attached oligomannoses activate B-cell receptor signaling pathways after engagement with calcium-dependent lectins expressed by tissue macrophages. This novel interaction appears critical for tumor growth and survival. To elucidate the significance of N-gly site presence and loss during ongoing SHM, we tracked site behavior during tumor evolution and progression in a diverse group of patients through next-generation sequencing. A hierarchy of subclones was visualized through lineage trees based on SHM semblance between subclones and their discordance from the germline sequence. We observed conservation of N-gly sites in more than 96% of subclone populations within and across diagnostic, progression, and transformation events. Rare N-gly-negative subclones were lost or negligible from successive events, in contrast to N-gly-positive subclones, which could additionally migrate between anatomical sites. Ongoing SHM of the N-gly sites resulted in subclones with different amino acid compositions across disease events, yet the vast majority of resulting DNA sequences still encoded for an N-gly site. The selection and expansion of only N-gly-positive subclones is evidence of the tumor cells' dependence on sites, despite the changing genomic complexity as the disease progresses. N-gly sites were gained in the earliest identified lymphoma cells, indicating they are an early and stable event of pathogenesis. Targeting the inferred mannose-lectin interaction holds therapeutic promise.

Lymphoid Neoplasia
0006-4971
834-844
Odabashian, Mariette
05bc5636-c7fe-4543-ad64-354f1f869127
Carlotti, Emanuela
779c686f-3d5f-418a-932d-d404e6df6730
Araf, Shamzah
260ff963-05c5-416c-b928-32a8ed7e1c50
Okosun, Jessica
4d3111dc-7937-4b49-a7a7-5e78b0884c25
Spada, Filomena
5336f6d7-7b18-4fcf-9cc0-23f5a26e9c45
Gribben, John
62dc9428-2e9d-4398-ac45-e8495884ec9c
Forconi, Francesco
ce9ed873-58cf-4876-bf3a-9ba1d163edc8
Stevenson, Freda
ba803747-c0ac-409f-a9c2-b61fde009f8c
Calaminici, Maria
fb0a4aa0-b277-4acf-941f-15d9015dde05
Krysov, Sergey
ef1f2040-8970-4f65-82a2-0c77b2b90299
Odabashian, Mariette
05bc5636-c7fe-4543-ad64-354f1f869127
Carlotti, Emanuela
779c686f-3d5f-418a-932d-d404e6df6730
Araf, Shamzah
260ff963-05c5-416c-b928-32a8ed7e1c50
Okosun, Jessica
4d3111dc-7937-4b49-a7a7-5e78b0884c25
Spada, Filomena
5336f6d7-7b18-4fcf-9cc0-23f5a26e9c45
Gribben, John
62dc9428-2e9d-4398-ac45-e8495884ec9c
Forconi, Francesco
ce9ed873-58cf-4876-bf3a-9ba1d163edc8
Stevenson, Freda
ba803747-c0ac-409f-a9c2-b61fde009f8c
Calaminici, Maria
fb0a4aa0-b277-4acf-941f-15d9015dde05
Krysov, Sergey
ef1f2040-8970-4f65-82a2-0c77b2b90299

Odabashian, Mariette, Carlotti, Emanuela, Araf, Shamzah, Okosun, Jessica, Spada, Filomena, Gribben, John, Forconi, Francesco, Stevenson, Freda, Calaminici, Maria and Krysov, Sergey (2020) IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution. Blood, 135 (11), 834-844. (doi:10.1182/blood.2019002279).

Record type: Article

Abstract

Follicular lymphoma B cells undergo continuous somatic hypermutation (SHM) of their immunoglobulin variable region genes, generating a heterogeneous tumor population. SHM introduces DNA sequences encoding N-glycosylation sites asparagine-X-serine/threonine (N-gly sites) within the V-region that are rarely found in normal B-cell counterparts. Unique attached oligomannoses activate B-cell receptor signaling pathways after engagement with calcium-dependent lectins expressed by tissue macrophages. This novel interaction appears critical for tumor growth and survival. To elucidate the significance of N-gly site presence and loss during ongoing SHM, we tracked site behavior during tumor evolution and progression in a diverse group of patients through next-generation sequencing. A hierarchy of subclones was visualized through lineage trees based on SHM semblance between subclones and their discordance from the germline sequence. We observed conservation of N-gly sites in more than 96% of subclone populations within and across diagnostic, progression, and transformation events. Rare N-gly-negative subclones were lost or negligible from successive events, in contrast to N-gly-positive subclones, which could additionally migrate between anatomical sites. Ongoing SHM of the N-gly sites resulted in subclones with different amino acid compositions across disease events, yet the vast majority of resulting DNA sequences still encoded for an N-gly site. The selection and expansion of only N-gly-positive subclones is evidence of the tumor cells' dependence on sites, despite the changing genomic complexity as the disease progresses. N-gly sites were gained in the earliest identified lymphoma cells, indicating they are an early and stable event of pathogenesis. Targeting the inferred mannose-lectin interaction holds therapeutic promise.

Text
IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during - Accepted Manuscript
Download (3MB)

More information

Accepted/In Press date: 13 December 2019
e-pub ahead of print date: 13 January 2020
Published date: 12 March 2020
Additional Information: Funding Information: as supported by grants from the Pathological Society of Great Britain and Ireland, Publisher Copyright: © 2020 by The American Society of Hematology
Keywords: Lymphoid Neoplasia

Identifiers

Local EPrints ID: 436801
URI: http://eprints.soton.ac.uk/id/eprint/436801
ISSN: 0006-4971
PURE UUID: 6823d3fd-909f-44ac-b9f7-401bc5d96a0d
ORCID for Francesco Forconi: ORCID iD orcid.org/0000-0002-2211-1831
ORCID for Freda Stevenson: ORCID iD orcid.org/0000-0002-0933-5021

Catalogue record

Date deposited: 09 Jan 2020 17:32
Last modified: 17 Mar 2024 05:10

Export record

Altmetrics

Contributors

Author: Mariette Odabashian
Author: Emanuela Carlotti
Author: Shamzah Araf
Author: Jessica Okosun
Author: Filomena Spada
Author: John Gribben
Author: Freda Stevenson ORCID iD
Author: Maria Calaminici
Author: Sergey Krysov

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×